Clinical Trials Logo

Septic Shock clinical trials

View clinical trials related to Septic Shock.

Filter by:

NCT ID: NCT05193682 Not yet recruiting - Septic Shock Clinical Trials

Right Ventricular Dysfunction in Septic Shock Patients in ICU

Septicshock
Start date: October 2022
Phase:
Study type: Observational

Assesment of right ventricular dysfunction in septic shock patients in intensive care unit.

NCT ID: NCT05159154 Not yet recruiting - Critical Illness Clinical Trials

Myocardial Work in Septic Shock Patients

MYWORKSS
Start date: January 1, 2022
Phase:
Study type: Observational

Myocardial strain analysis has emerged in the last decade as a reliable tool for studying myocardial mechanics, adding information on cardiac performance when compared with traditional parameters of left ventricle (LV) systolic function, such as ejection fraction (EF). However, their relative load dependency makes the myocardial deformation indices unable to account for changes in pre- and afterload. Myocardial work (MW) is emerging as an alternative tool for studying LV myocardial systolic function, because it incorporates both deformation and load into its analysis. The purpose of this observational trial is to validate the use of MW in septic shock patients by means of consecutive echocardiographic assessment at predefined timepoints. Secondarily, we'll evaluate the impact of the vasoactive drugs used in septic shock patients (vasopressors and inotropes) on MW and on ventriculo-arterial coupling.

NCT ID: NCT05080543 Not yet recruiting - Septic Shock Clinical Trials

Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients

Start date: October 2021
Phase: Phase 1
Study type: Interventional

The aim of this study is to evaluate the effect of combining HSA 20% and terlipressin on the microcirculation in patients with septic shock using the following;- - Microcirculation recruitment by Cytocam-IDF. - Cardiac output by LiDCOrapid. - Measuring serum lactate level.

NCT ID: NCT04913181 Not yet recruiting - Septic Shock Clinical Trials

Artificial Intelligence for Sepsis Prediction in ICU

AICUSepsis
Start date: June 1, 2021
Phase:
Study type: Observational

The development of sepsis prediction model in line with Chinese population, and extended to clinical, assist clinicians for early identification, early intervention, has a good application prospect. This study is a prospective observational study, mainly to evaluate the accuracy of the previously established sepsis prediction model. The occurrence of sepsis was determined by doctors' daily clinical judgment, and the results of the sepsis prediction model were matched and corrected to improve the clinical accuracy and applicability of the sepsis prediction model.

NCT ID: NCT04903405 Not yet recruiting - Sepsis Clinical Trials

Immune Function Monitoring and Immunotherapy in Sepsis

IMITS
Start date: June 1, 2021
Phase:
Study type: Observational [Patient Registry]

At present, the clinical studies of various anti-inflammatory drugs and immune-enhancing drugs show that immunotherapy will bring new hope for the treatment of sepsis. In order to further understand the current status of immunotherapy in China, this study aims to understand the current status and standardization of the use of sepsis immunosurveillance and immunotherapy in hospitals through a cross-sectional survey.

NCT ID: NCT04693923 Not yet recruiting - Septic Shock Clinical Trials

Capillary Refill Time Response to a Rapid Fluid Challenge in Septic Shock Patients

AUSTRALIS
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

In septic shock patients, the hemodynamic coherence between systemic, regional and microcirculatory blood flow can be tracked by "capillary refill time (CRT) response to an increase in stroke volume induced by a rapid fluid challenge". A parallel improvement in regional blood flow, microcirculation and hypoperfusion-related parameters should be expected in CRT-responders as reflection of preserved hemodynamic coherence. CRT non-response is associated with a more severe systemic inflammatory state, endothelial and microvascular dysfunction, and a higher adrenergic tone. The objective of this study is to determine if CRT response after a rapid fluid challenge signals a state of hemodynamic coherence as demonstrated by a parallel improvement in regional and microcirculatory blood flow in CRT-responders, and to explore the pathophysiological mechanisms associated to CRT non-response.

NCT ID: NCT04690530 Not yet recruiting - Septic Shock Clinical Trials

Cerebral Hemodynamics and Oxygenation in Critically Ill Patients

Start date: March 1, 2022
Phase:
Study type: Observational

Critically-ill patients frequently experience marked changes in mean arterial pressure and carbon dioxide partial arterial pressure, the two major determinants of the cerebral blood flow. In addition, many therapeutics (fluids, vasopressors or inotropes administration, blood transfusion, prone positioning...) can influence these two determinants of cerebral blood flow and thus cerebral blood flow, especially in patients with altered cerebral autoregulation. Nevertheless, cerebral hemodynamics and oxygenation, as well as the effects of the different therapeutics on it have been poorly studied in critically-ill patients. In addition, it has been suggested that impaired cerebral blood flow and impaired cerebral microcirculation may be involved in the pathophysiology of septic encephalopathy in patients with sepsis and/or septic shock. In this study, we aimed to characterize and investigate the effects of different therapeutics on cerebral hemodynamics and oxygenation in critically-ill patients.

NCT ID: NCT04516395 Not yet recruiting - Sepsis Clinical Trials

Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae

Start date: September 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the treatment outcomes in patients with CRE infections.

NCT ID: NCT04449757 Not yet recruiting - Septic Shock Clinical Trials

Bicarbonated Ringer's Solution Versus Lactated Ringer's Solution in Patients With Septic Shock

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

In this prospective randomized controlled trial, investigators aim to study the effects and safety of bicarbonated Ringer's solution in patients with septic shock compared with lactated ringer's solution, and provide evidence for current fluid resuscitation strategies for septic shock.

NCT ID: NCT04365010 Not yet recruiting - Septic Shock Clinical Trials

Low-chlorine Vs High-chlorine Crystalloids in Septic Shock Adults

Start date: May 2020
Phase: Phase 4
Study type: Interventional

Fluid resuscitation is an important treatment in septic shock patients, however whether crystalloid composition affects septic shock patients outcomes remains unclear. According to previous studies, low-chlorine crystalloids could significantly reduce the incidence of kidney injury and 30-day mortality compared with high-chlorine crystalloids in critically ill adults. Therefore, we hypothesized that the use of low-chlorine crystalloids would result in a lower incidence of major adverse kidney events within 30 days (MAKE 30: overall incidence of death, new renal-replacement therapy, and persistent renal dysfunction) than high-chlorine crystalloids in septic shock adults.